Abiomed: Manufacturer of Impella®Percutaneous Ventricular Assist Device
Abiomed, founded in 1981, is a global pioneer in healthcare technology, with a mission to recover hearts and save lives.
From the World’s first total replacement heart pump to the World’s smallest heart pump, Abiomed has developed a family of ventricular assist devices (VAD), namely the Impella® platform of percutaneous…
View more
Job title: Interventional Cardiologist
Dr Sara C Martinez is an Interventional Cardiologist at Providence Health and Services in Olympia, Washington. Prior to her current appointment, Dr Martinez was an Interventional Cardiology Fellow at the Mayo Clinic, Rochester, and a Post-Doctoral Fellow at the Sharon Cresci Lab and Washington University School of Medicine. Dr Martinez also completed her residency in internal medicine at the…
View more
Job title: Interventional Cardiologist
Dr Carlos Colletpractices as an interventional cardiologist at Olv Hospital Aalst, Aalst, BE.Dr Collet earned a doctorate in Cardiovascular Sciences from the University of Amsterdam. During his doctoral studies, he devoted his research to the integration of coronary imaging and physiology in patients with complex coronary artery disease.He has published over 300 peer-reviewed articles and serves…
View more
Author(s):
Donald E Cutlip
Added:
3 years ago
The Editorial Board and staff are pleased to present the latest issue of US Cardiology Review. Ten timely reviews and a clinical trial perspective represent six different subspecialty sections, and the issue concludes with a special personal perspective on the pros and cons of early retirement from medical practice by Elizabeth Ross. Perhaps everyone has had that thought at one time or another!
…
View more
Job title: Associate Professor
Dr Navin K Kapur, MD, FAHA, FACC, FSCAI is Executive Director, The CardioVascular Center for Research and Innovation (CVCRI); Director, Acute Mechanical Circulatory Support Program; Director, Interventional Research Laboratories; Director of Cardiac Biology Research Center, Molecular Cardiology Research Institute (MCRI); Associate Professor, Tufts University School of Medicine.
Dr Kapur's…
View more
Author(s):
Hans P Niendorf,
P Lengsfeld,
M Bräutigam
Added:
3 years ago
Contrast-induced nephropathy (CIN) in the actual essence of the term refers to renal damage induced by a contrast medium. The ultimate clinical manifestation of CIN is renal failure requiring dialysis, and this article will concentrate on CIN as a clinical outcome. However, transient rises in serum creatinine have been frequently used as a surrogate marker that is suggested to predict renal…
View more
Author(s):
Adrian P Banning
Added:
2 years ago
In this interview, Professor Adrian Banning (John Radcliffe Hospital, Oxford, UK) discusses the five-year outcomes of the SYNTAX II trial. This study aims to evaluate the impact of new technologies in percutaneous coronary intervention (PCI) by comparing the outcomes of these procedures to the original SYNTAX trial. The study showed that PCI moved forward considerably in the last 5 years, it is…
View more
Author(s):
Mirvat Alasnag
Added:
1 year ago
In this short and practice focused review, Dr Mirvat Alasnag (The King Fahd Armed Forces Hospital, Jeddah, SA) highlights some of the late-breaking clinical trials presented atACC.22from an interventionalist perspective.
Trials covered in detail include:
00:58: SODIUM-HF: Study of Dietary Intervention Under 100 Mmol in Heart Failure
01:46: GHATI: Improving STEMI Management Internationally: Two…
View more